{"symbol":"GILD","fiscalQuarter":"Q1-2025","reportDate":"2025-04-24","reportTime":"AMC","status":"reported","company":{"name":"Gilead Sciences, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/GILD/earnings/Q1-2025","postBrief":{"headline":"Gilead Sciences Beats on EPS, Stock Reaction Not Available","keyNumbers":[{"metric":"EPS","actual":"$1.81","expected":"N/A","surprise":"+3.31%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed confidence in the ongoing pipeline developments.","They highlighted the importance of upcoming product launches.","The team is focused on maintaining operational efficiency."],"summary":"Overall, management conveyed a positive outlook regarding their product pipeline and operational strategies. However, they did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Gilead Sciences reported a positive surprise in EPS, indicating better-than-expected profitability for the quarter. However, the lack of revenue data and guidance leaves some uncertainty about future performance. The stock reaction is currently unavailable, making it difficult to assess immediate market sentiment.","metaDescription":"Gilead Sciences (GILD) Q1 2025 earnings: EPS beat by 3.31%. Stock reaction not available. Full breakdown."}}